Table 2.
Summary of included studies. References are reported in the Supplementary Material.
| Outcome | Number of studies | Number of patients | Effect estimate (95%CI, p) |
|---|---|---|---|
| In-hospital mortality | 18 | 123,923 | OR= 0.94 (0.83-1.07, p=0.35) |
| ICU mortality | 16 | 56,408 | OR= 0.94 (0.79-1.13, p=0.51) |
| ICU LOS | 22 | 48,222 | SMD= 0.23 (0.11-0.35, p<0.01) |
| ECMO implantation | 11 | 10,019 | OR= 1.64 (1.06-2.52, p=0.03) |
| Mechanical ventilation time | 14 | 8,870 | SMD= 0.10 (-0.01-0.21, p=0.09) |
| Hospital LOS | 14 | 16,343 | SMD= 0.10 (-0.04-0.24, p=0.17) |
| Systemic thromboembolism | 9 | 3,135 | OR= 1.25 (0.82-1.91, p=0.29) |
| Myocarditis | 6 | 6,330 | OR= 1.49 (0.72-3.07, p=0.28) |
| Ventilator associated pneumonia | 6 | 5,583 | OR= 0.78 (0.51-1.18, p=0.24) |
CI, confidence interval; ECMO, extracorporeal membrane oxygenation; LOS, length of stay; SMD, standard mean difference; OR, odds ratio.